Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...

In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA).

Nat Clin Pract Nephrol. 2007;3(6):296-297. How did this transfer of 'ownership' of lupus nephritis to rheumatologists happen? There are two possible reasons. Either rheumatologists hijacked lupus ...

The landscape of lupus nephritis treatment is poised to change in coming years. In keeping with recent successes in treating lupus nephritis, such as the FDA approvals of belimumab and voclosporin, ...

Robert S. Katz, MD BOSTON—A widely used classification scheme for lupus glomerulonephritis (GN) may mask the pathologic and prognostic implications of focal segmental lupus GN, according to ...

Arising from: Kallenberg CGM and Bijl M (2008) Why rheumatologists should be involved in the treatment of lupus nephritis. Nat Clin Pract Nephrol [doi:10.1038 ...

Returning from the 2024 ACR Convergence, Dr Askanase highlights the presentation of the new 2024 American College of Rheumatology guidelines for lupus nephritis as the most impactful session at this ...

The long-anticipated results of the Aspreva Lupus Management Study (ALMS) have finally been published. 1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over ...

The 15-44 age range of women faces elevated danger from this condition, which shows hereditary patterns because of both ...

Please provide your email address to receive an email when new articles are posted on . ATA3219 is an allogeneic CAR T-cell therapy being investigated in the treatment of SLE with lupus nephritis. The ...

LONDON--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Benlysta (belimumab) for the treatment of children aged 5 to 17 with active ...

The American College of Rheumatology last published recommendations for managing lupus nephritis (LN) in 2012. Since then, targeted treatments including belimumab (Benlysta) and voclosporin (Lupkynis) ...